Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Esserman

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Annals of African Medicine|June 12, 2012
Biology of breast cancer in Nigerian women: a pilot studyC A Adisa, N Eleweke, Au A Alfred, et al.
Ultrasonic Imaging|July 1, 1996
Ultrasound tissue characterization of breast biopsy specimens: expanded studyC L Mortensen, P D Edmonds, Y Gorfu, et al.
Clinical Pharmacology and Therapeutics|September 20, 2016
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial PlatformsM R Trusheim, A A Shrier, Z Antonijevic, et al.
Breast Cancer Research and Treatment|January 29, 2014
Mammographic screening detects low-risk tumor biology breast cancersC A Drukker, M K Schmidt, E J T Rutgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaborationV Bossuyt, E Provenzano, W F Symmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2020
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survivalM J M Magbanua, L B Swigart, H-T Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.
Journal of the National Cancer Institute|November 8, 2001
Ductal lavage for detection of cellular atypia in women at high risk for breast cancerW C Dooley, B M Ljung, U Veronesi, et al.
Annals of Surgical Oncology|August 21, 2025
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 TrialM Kaur, K Dimitroff, J C Boughey, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Annals of African Medicine|June 12, 2012
Biology of breast cancer in Nigerian women: a pilot studyC A Adisa, N Eleweke, Au A Alfred, et al.
Ultrasonic Imaging|July 1, 1996
Ultrasound tissue characterization of breast biopsy specimens: expanded studyC L Mortensen, P D Edmonds, Y Gorfu, et al.
Clinical Pharmacology and Therapeutics|September 20, 2016
PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial PlatformsM R Trusheim, A A Shrier, Z Antonijevic, et al.
Breast Cancer Research and Treatment|January 29, 2014
Mammographic screening detects low-risk tumor biology breast cancersC A Drukker, M K Schmidt, E J T Rutgers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2015
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaborationV Bossuyt, E Provenzano, W F Symmans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2020
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survivalM J M Magbanua, L B Swigart, H-T Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.
Journal of the National Cancer Institute|November 8, 2001
Ductal lavage for detection of cellular atypia in women at high risk for breast cancerW C Dooley, B M Ljung, U Veronesi, et al.
Annals of Surgical Oncology|August 21, 2025
ASO Visual Abstract: Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 TrialM Kaur, K Dimitroff, J C Boughey, et al.
Pageof 3